Osaka, Japan

Mariko Oi


 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Mariko Oi: Pioneering Patent Holder in Osaka

Introduction: Mariko Oi is a distinguished inventor based in Osaka, Japan, renowned for her significant contributions to the realm of pharmaceuticals. With a total of three patents to her name, she has made remarkable strides in the development of compounds that target specific receptors in the body, improving therapeutic outcomes.

Latest Patents: Among her latest innovations, Mariko Oi has developed a series of pyrazolo[1,5-a]pyrimidine compounds that act as CB1 receptor antagonists. These compounds are characterized by a unique formula where R and R' can represent the same or different optionally substituted aryl groups. This invention holds potential for various medical applications, targeting receptors involved in crucial biological processes.

Another significant patent encompasses novel pyrazolo[1,5-a]pyrimidine compounds, further emphasizing her focus on advancing drug development. These compounds also feature a specific formula that integrates an optionally substituted aryl group, showcasing her expertise in creating targeted pharmaceutical solutions.

Career Highlights: Currently, Mariko Oi is affiliated with Mitsubishi Tanabe Pharma Corporation, a prominent organization dedicated to advancing healthcare through innovative pharmaceuticals. Her role within the company involves extensive research and development that aims to bring groundbreaking therapeutic options to patients.

Collaborations: Throughout her career, Mariko has collaborated with esteemed colleagues, including Yasunori Moritani and Koichi Tanimoto. These collaborations reflect the importance of teamwork in driving innovation and enhancing the impact of their collective research efforts.

Conclusion: Mariko Oi's contributions to the field of pharmacology, particularly through her patented innovations in pyrazolo[1,5-a]pyrimidine compounds, underscore her impact on medical science. Her work at Mitsubishi Tanabe Pharma Corporation and her collaborations with fellow researchers exemplify the collaborative spirit in the quest for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…